Summary: The article examines the Supreme Court’s decision in Sanofi India Ltd. v. Central Bureau of Investigation, which lays down a three-stage framework for determining when a natural person’s act and mens rea may be attributed to a company. The
Cyril Amarchand Mangaldas is a leading Indian law firm with a global reputation, advising a diverse clientele including domestic and international commercial enterprises, financial institutions, private equity and venture capital funds, startups, and government bodies. The firm publishes content primarily focused on legal developments and analysis across a broad range of practice areas such as corporate governance, competition law, employment, ESG, intellectual property, mergers and acquisitions, private equity, public policy, real estate, taxation, banking and finance, insolvency, arbitration, litigation, white collar investigations, and capital markets. Their publications include blogs, newsletters, articles, podcasts, and videos that provide insights into recent legal rulings, regulatory changes, and sector-specific issues relevant to practitioners and clients.
Summary: India’s healthcare delivery has long been shaped by two extremes: small clinics offering basic consultation and large corporate hospitals delivering advanced tertiary care. Micro-hospitals, typically comprising 15 to 75 beds, have emerged as the “missing middle”, combining lean infrastructure,…